Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma
Clinical trial NCT03108027 · COMPLETED
Trial details
- NCT number
- NCT03108027
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2018-02-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.